Dear Patient,
It is our aim here at EBS to make our low-risk therapy available to doctors and their patients as soon as possible. To do so the EBS NEXT WAVE™ technology is currently being studied in a series of carefully designed clinical trials. These studies are focused on establishing the safety and effectiveness of the system in reducing vision defects after stroke or brain injury.
If you are interested to either take part in one of our current trials or would like to be informed as soon as the therapy is commercially available please use the contact option below.
